Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

OTLK US Equity

Outlook Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1649989 · FY ends Sep 30
$0.69
-0.01 (-1.41%)
USD · as of 2026-08-19 · marketstack
6 8-K filings · 1 13D · 1 13G
DateEventWhat happened / filerSource
2026-08-1913GSchedule 13G filed — ≥5% beneficial owner (passive) · by CVI Investments, Inc.sec.gov ↗
2026-08-1413D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by GMS Ventures & Investmentssec.gov ↗
2026-08-148-K 8.01Other eventssec.gov ↗
2026-08-148-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-128-K 8.01Other eventssec.gov ↗
2026-08-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-248-K 8.01Other eventssec.gov ↗
2026-07-238-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-07-168-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-07-168-K 5.03Amendments to articles of incorporation or bylaws; fiscal year changesec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-16

Every row is a filed document, checked against its EDGAR index.